The global spatial genomics and transcriptomics market is expected to grow from USD 355 million in 2022 to USD 800 million by 2027, exhibiting a robust CAGR of 17.6%. This growth is primarily driven by the increasing adoption of spatial genomics and transcriptomics techniques in drug discovery and development. Additionally, the rise in research and development investments and public-private funding, along with the introduction of technologically advanced instruments, are propelling market expansion.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551
Understanding Market Dynamics
Spatial Transcriptomics Techniques Lead the Market
The spatial genomics and transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. In 2021, spatial transcriptomics techniques accounted for the largest share of the global market. This growth is attributed to their high adoption in drug discovery and development, the introduction of novel products, and increasing research and development investments.
Consumables Segment Drives spatial genomics & transcriptomics market Growth
Among product segments, consumables emerged as the largest-growing segment of the spatial genomics and transcriptomics market in 2021. The increasing applications of spatial genomics and transcriptomics in drug discovery and development, biomarker identification, and the growing use of consumables are key factors driving market growth.
North America Leads the spatial genomics & transcriptomics market
North America holds the largest share in the global spatial genomics and transcriptomics market, followed by Europe. The region’s dominant position is due to the rising focus on drug discovery and development, driven by the growing incidence of chronic and genetic diseases, as well as the rapidly growing aging population. These factors support the widespread adoption of spatial genomics and transcriptomics technologies in the region.
Key Market Players
The spatial genomics and transcriptomics market is characterized by its consolidated nature, with several prominent players leading the industry. Key players include NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic Vision SA (France), Akoya Biosciences, Inc. (US), and Danaher Corporation (US), among others.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170900551
Conclusion
The spatial genomics and transcriptomics market is witnessing significant growth, driven by advancements in technology and increased research and development activities. As the demand for precise and efficient diagnostic tools rises, the market is expected to expand further. With key players focusing on innovation and the development of advanced instruments, the future of spatial genomics and transcriptomics looks promising.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
